Silvercrest Asset Management Group LLC

SEC CIK: 0001232395
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Silvercrest Asset Management Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2025

Holdings of APLS by Silvercrest Asset Management Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−190,759−100.0%	Sold out	Holders
Q4 2025	190,759	$4.79M	<0.1%	+233+0.1%	Added	Holders
Q3 2025	190,526	$4.31M	<0.1%	+190,526	New	Holders